Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schacker

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
JAMA|July 11, 1998
Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected menT Schacker, A J Ryncarz, J Goddard, et al.
The Journal of Infectious Diseases|June 1, 1994
Human herpesvirus 6 DNA in blood cells of human immunodeficiency virus-infected men: correlation of high levels with high CD4 cell countsM R Fairfax, T Schacker, R W Cone, et al.
The New England Journal of Medicine|November 5, 1997
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infectionL Musey, J Hughes, T Schacker, et al.
American Journal of Obstetrics and Gynecology|August 1, 1997
Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1J Hitti, D H Watts, S K Burchett, et al.
Journal of Virology|June 1, 1997
Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responsesS L Liu, T Schacker, L Musey, et al.
Annals of Internal Medicine|January 10, 1998
Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trialT Schacker, H L Hu, D M Koelle, et al.
The Journal of Infectious Diseases|January 1, 1994
The effects of high-dose recombinant soluble CD4 on human immunodeficiency virus type 1 viremiaT Schacker, R W Coombs, A C Collier, et al.
The New England Journal of Medicine|November 9, 2000
Mucosal shedding of human herpesvirus 8 in menJ Pauk, M L Huang, S J Brodie, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1995
Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infectionT Schacker, A C Collier, R Coombs, et al.
The Journal of Infectious Diseases|December 23, 1999
Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infectionU Malhotra, M M Berrey, Y Huang, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
JAMA|July 11, 1998
Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected menT Schacker, A J Ryncarz, J Goddard, et al.
The Journal of Infectious Diseases|June 1, 1994
Human herpesvirus 6 DNA in blood cells of human immunodeficiency virus-infected men: correlation of high levels with high CD4 cell countsM R Fairfax, T Schacker, R W Cone, et al.
The New England Journal of Medicine|November 5, 1997
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infectionL Musey, J Hughes, T Schacker, et al.
American Journal of Obstetrics and Gynecology|August 1, 1997
Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1J Hitti, D H Watts, S K Burchett, et al.
Journal of Virology|June 1, 1997
Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responsesS L Liu, T Schacker, L Musey, et al.
Annals of Internal Medicine|January 10, 1998
Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trialT Schacker, H L Hu, D M Koelle, et al.
The Journal of Infectious Diseases|January 1, 1994
The effects of high-dose recombinant soluble CD4 on human immunodeficiency virus type 1 viremiaT Schacker, R W Coombs, A C Collier, et al.
The New England Journal of Medicine|November 9, 2000
Mucosal shedding of human herpesvirus 8 in menJ Pauk, M L Huang, S J Brodie, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1995
Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infectionT Schacker, A C Collier, R Coombs, et al.
The Journal of Infectious Diseases|December 23, 1999
Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infectionU Malhotra, M M Berrey, Y Huang, et al.
Pageof 3